He has a PhD in Genomics and spent more than ten years doing research in biotechnology and genetics, with over 35 papers published in high-impact scientific journals. In 2013, he founded Sequentia with Riccardo Aiese Cigliano and currently balances his position at the helm of the company with teaching, giving classes in genomics at universities in Spain (UAB and UPF) and Italy (Sapienza, in Roma, and Federico II, in Naples). He is a councilor for the Italian Society of Agricultural Genetics (SIGA) and works to promote proper use of green biotechnology.
PhD in Chemistry from the University of Barcelona, his early career as a researcher was focused on the design and synthesis of bioactive peptides. He undertook postdoctoral studies in protein engineering and chemistry at the University of Rockefeller (New York) for six years. Later he joined Princeton University and headed the protein spectroscopy unit at the Department of Chemistry. He returned to Barcelona in 2014 and co-founded ProteoDesign, of which he is CEO and Chief Science Officer.
Josep M. Escuer is an industrial engineer, PDD by ESADE. After 20 years in the automotive sector, he turned to health technology, where he has been working in business development, marketing and sales for 8 years. He is co-founder and CEO of QREM. Núria Noguera is a physicist and material engineer. She has been developing medical products for 16 years, the last 13 years in private companies transforming the ideas and needs of medical professionals into commercial products. She is Co-Founder and CTO of QREM.
Doctor in Biology and PDD at IESE, after a few years as a researcher in molecular biology Jesús Purroy was the Scientific Director of the Parc Científic de Barcelona. Àvida Biotech is the second biotech startup he co-founds. He has been involved in other entrepreneurship projects as a mentor or consultant. He devotes part of his time to communication of science in the form of books and lectures.
Maria Pau Ginebra is a professor at the UPC and an associate researcher at the IBEC. In 2013, she co-founded Mimetis Biomaterials, a spin-off of the UPC that is developing new biomaterials for bone regeneration. She is the only Catalan among the twelve finalists for the 2018 EU Prize for Women Innovators, which will be awarded in June.
Co-Founder, CEO-CFO and Financial Chief of MJN Neuroserveis
Salva Gutiérrez is an economist and has a degree in Business Administration and Management. He is an investment and equity manager, with more than 25 years of experience in family offices. In 2012, with David Blánquez and Xavier Raurich, he founded MJN Neuroserveis, motivated by the daughter of one of the founders, who has epilepsy. They’ve developed a device to predict seizures in patients with this condition.